Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study

被引：0
|
作者：
Anderson, K.
Stamler, D.
Davis, M.
Factor, S.
Hauser, R.
Isojarvi, J.
Jarskog, L.
Jimenez-Shahed, J.
Kumar, R.
Ochudlo, S.
Ondo, W.
Fernandez, H.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
402
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TARDIVE-DYSKINESIA AND THE LONG-TERM PATIENT
    SCHWARTZ, HJ
    [J]. HOSPITAL AND COMMUNITY PSYCHIATRY, 1979, 30 (07): : 465 - 467
  • [42] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
  • [43] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
  • [44] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [45] Long-term treatment effects of vitamin E for tardive dyskinesia
    Adler, LA
    Edson, R
    Lavori, P
    Peselow, E
    Duncan, E
    Rosenthal, M
    Rotrosen, J
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 (12) : 868 - 872
  • [46] Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study
    Jankovic, Joseph
    Coffey, Barbara
    Claassen, Daniel O.
    Jimenez-Shahed, Joohi
    Gertz, Barry J.
    Garofalo, Elizabeth A.
    Stamler, David A.
    Wieman, Maria
    Savola, Juha-Matti
    Harary, Eran
    Alexander, Jessica
    Barkay, Hadas
    Gordon, Mark Forrest
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (09): : 1388 - 1398
  • [47] Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Singer, Carlos
    Comella, Cynthia
    Marder, Stephen
    Farahmand, Khodayar
    Jimenez, Roland
    [J]. NEUROLOGY, 2020, 94 (15)
  • [48] TARDIVE-DYSKINESIA AFTER LONG-TERM TREATMENT WITH METOCLOPRAMIDE
    HEINZE, HJ
    KOLBE, H
    [J]. AKTUELLE NEUROLOGIE, 1983, 10 (05) : 167 - 168
  • [49] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [50] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
12345